Vedolizumab levels in breast milk: Results from a prospective, postmarketing, milk-only lactation study in nursing mothers with inflammatory bowel disease

被引：0
|
作者：
Sun, W. [1 ]
Fennimore, B. [2 ]
Beaulieu, D. B. [3 ]
Arsenescu, R. [4 ]
Stein, A. [5 ]
Chen, J. [6 ]
Lin, T. [7 ]
McKnight, S. [8 ]
Rosario, M. [9 ]
Lirio, R. A. [10 ]
机构：
[1] Takeda, Quantitat Clin Pharmacol, Cambridge, MA USA
[2] Univ Colorado, Dept Med Gastroenterol, Aurora, CO USA
[3] Vanderbilt Univ, Med Ctr, Vanderbilt Digest Dis Ctr, Nashville, TN USA
[4] AHS Hosp Corp, Morristown Med Ctr, Morristown, NJ USA
[5] Northwestern Univ, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA
[6] Takeda, Stat & Quantitat Sci, Cambridge, MA USA
[7] Certara, Integrated Drug Dev, Princeton, NJ USA
[8] Takeda, Global Program Management, Cambridge, MA USA
[9] Takeda, Clin Pharmacol, Cambridge, MA USA
[10] Takeda, Clin Sci, Cambridge, MA USA
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P509
引用
收藏
页码：S442 / S442
页数：1
相关论文
共 50 条
  • [41] Influence of Early Life Factors, including breast milk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease (vol 17, pg 1723, 2023)
    不详
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (07): : 1174 - 1174
  • [42] Acceptability of treatment regimen in inflammatory bowel disease: Results from a prospective nationwide study (ACCEPT2)
    Buisson, A.
    Fumery, M.
    Serrero, M.
    Orsat, L.
    Nancey, S.
    Riviere, P.
    Altwegg, R.
    Peyrin-Biroulet, L.
    Nachury, M.
    Hebuterne, X.
    Gilletta, C.
    Flamant, M.
    Viennot, S.
    Bouguen, G.
    Amiot, A.
    Mathieu, S.
    Vuitton, L.
    Plastaras, L.
    Bourreille, A.
    Caillo, L.
    Goutorbe, F.
    Fumery, M.
    de Chambrun, G. Pineton
    Attar, A.
    Roblin, X.
    Pereira, B.
    Pariente, B.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S337 - S338
  • [43] Is Clostridium difficile Associated With Relapse of Inflammatory Bowel Disease? Results From a Retrospective and Prospective Cohort Study in the Netherlands
    Masclee, Gwen M. C.
    Penders, John
    Jonkers, Daisy M. A. E.
    Wolffs, Petra F. G.
    Pierik, Marie J.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (10) : 2125 - 2131
  • [44] ACCEPTABILITY OF TREATMENT REGIMEN IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM A PROSPECTIVE NATIONWIDE STUDY (ACCEPT2).
    Buisson, Anthony
    Fumery, Mathurin
    Serrero, Melanie
    Orsat, Laurie
    Nancey, Stephane
    Riviere, Pauline
    Altwegg, Romain
    Peyrin-Biroulet, Laurent
    Nachury, Maria
    Hebuterne, Xavier
    Gilletta, Cyrielle
    Flamant, Mathurin
    Viennot, Stephanie
    Bouguen, Guillaume
    Amiot, Aurelien
    Mathieu, Stephane
    Vuitton, Lucine
    Plastaras, Laurianne
    Bourreille, Arnaud
    Caillo, Ludovic
    Goutorbe, Felix
    de Chambrun, Guillaume Pineton
    Attar, Alain
    Roblin, Xavier
    Pereira, Bruno
    Pariente, Benjamin
    GASTROENTEROLOGY, 2020, 158 (06) : S405 - S406
  • [45] Real-world evidence on effectiveness and safety of vedolizumab therapy for inflammatory bowel disease in Taiwan: Results from the TSIBD registry (VIOLET Study)
    Wei, S. C.
    Lin, W. C.
    Chang, C. H.
    Tu, C. H.
    Feng, I. C.
    Shieh, M. J.
    Chung, C. S.
    Yen, H. H.
    Chou, J. W.
    Tai, W. C.
    Wong, J. M.
    Liu, Y. H.
    Huang, T. Y.
    Chuang, C. H.
    Tsai, T. J.
    Chiang, F. F.
    Lu, C. Y.
    Hsu, W. H.
    Yu, F. J.
    Chao, T. H.
    Wu, D. C.
    Ho, A. S.
    Lin, H. H.
    Feng, C. L.
    Wu, K. L.
    Wong, M. W.
    Tung, C. C.
    Lin, C. C.
    Chen, C. C.
    Hu, H. M.
    Lu, L. S.
    Wang, H. S.
    Wu, I. C.
    Kuo, H. Y.
    Wu, J. F.
    Shih, H. Y.
    Ni, Y. H.
    Tang, S. L.
    Chang, H. C.
    Chen, P. H.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S428 - S430
  • [46] Does a High-inflammatory Diet Increase the Risk of Inflammatory Bowel Disease? Results From the Prospective Urban Rural Epidemiology (PURE) Study: A Prospective Cohort Study
    Narula, Neeraj
    Wong, Emily C. L.
    Dehghan, Mahshid
    Marshall, John K.
    Moayyedi, Paul
    Yusuf, Salim
    GASTROENTEROLOGY, 2021, 161 (04) : 1333 - +
  • [47] Dose intensification of subcutaneous vedolizumab is an effective and safe option in Inflammatory Bowel Disease patients: Results from the multicentre OPTI-VEDO study
    Wils, P.
    Altwegg, R.
    Buisson, A.
    Vuitton, L.
    Nancey, S.
    Richard, N.
    Fumery, M.
    Bouguen, G.
    Guillo, L.
    Caron, B.
    Duveau, N.
    Stefanescu, C.
    Pelletier, A. L.
    Reenaers, C.
    Gilletta, C.
    Uzzan, M.
    Arab, N.
    Laharie, D.
    Vidon, M.
    Amiot, A.
    Le Berre, C.
    Kirchgesner, J.
    Dewit, O.
    Simon, M.
    Goutorbe, F.
    Vicaut, E.
    Peyrin-Biroulet, L.
    GETAID Grp
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1380 - i1380
  • [48] Selenium levels and their association with thyroid autoimmunity and severe preeclampsia in pregnancy: Insights from a prospective ideal breast milk cohort study
    Chung, Chae Won
    Kim, Kyungsik
    Park, Sue K.
    Ju, Dal Lae
    Park, Young Joo
    Shin, Choong Ho
    Jun, Jong Kwan
    Chung, June-Key
    Song, Yoon Ju
    Lee, Young Ah
    Cheon, Gi Jeong
    Cho, Sun Wook
    EUROPEAN THYROID JOURNAL, 2024, 13 (04)
  • [49] Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort
    May-Bente Bengtson
    Christopher F. Martin
    Geir Aamodt
    Morten H. Vatn
    Uma Mahadevan
    Digestive Diseases and Sciences, 2017, 62 : 2063 - 2069
  • [50] Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort
    Bengtson, May-Bente
    Martin, Christopher F.
    Aamodt, Geir
    Vatn, Morten H.
    Mahadevan, Uma
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (08) : 2063 - 2069
12345